Modlin I M, Jaffe B M, Sank A, Albert D
Ann Surg. 1982 Nov;196(5):512-7. doi: 10.1097/00000658-198211000-00002.
Despite the increasing awareness of gastrinoma and its lethal peptic ulcer sequelae, the diagnosis is often initially missed or made as a terminal event. The authors screened all patients with peptic ulcer symptoms serious enough to warrant hospital admission or those associated with diarrhea, nephrolithiasis, hypercalcemia, or pituitary abnormality. In a one-year period (1979-1980) nine (of 14 suspected) new gastrinoma patients were identified using a sensitive and specific gastrin radioimmunoassay in combination with provocative tests including IV secretin, calcium, and food. Conventional upper GI series, CAT scan, arteriography, and endoscopy provided no additional information other than to confirm the presence of ulcer disease. Basal plasma gastrin levels were more than 200 pmol L-1 in only three of the nine (normal fasting plasma gastrin levels are less than 25 pmol L-1). Three patients presented with acute ulcer perforation, and the diagnosis of gastrinoma was suspected because of multiple ulcers and pancreatic masses. In three other patients, previous duodenal ulcer surgery had failed. One patient with dyspepsia, high basal plasma gastrin, negative secretin and calcium infusion studies, and a positive meal test was diagnosed as having G-cell hyperplasia; this was confirmed by biopsy and antral gastrin extraction. Antrectomy alone resulted in cure. In all patients tested, a positive calcium infusion or secretin bolus (greater than 100% rise over basal) strongly suggested the diagnosis of gastrinoma, which was confirmed at surgery. In the acute perforations, initial management with omental patch and cimetidine therapy allowed survival of two patients, while emergency total gastrectomy in the third resulted in death due to esophagojejunal leak. Elective patients were treated with cimetidine initially for at least two weeks before total gastrectomy. In this group there were no operative mortalities, and postoperative morbidity was minimal. This series illustrates three important points: (1) careful screening of an ulcer population using gastrin radioimmunoassay and provocative tests has enabled a high yield of gastrinomas while conventional investigations are of minimal values; (2) a high index of suspicion in appropriate cases is necessary; and (3) total gastrectomy performed under elective circumstances is safe and allows the patients to resume a normal and healthy life without the sequelae of aggressive peptic ulceration or daily drug administration.
尽管人们对胃泌素瘤及其致命的消化性溃疡后遗症的认识不断提高,但诊断往往在最初被漏诊或在病情晚期才得以做出。作者对所有因消化性溃疡症状严重到需要住院治疗或伴有腹泻、肾结石、高钙血症或垂体异常的患者进行了筛查。在1979年至1980年的一年时间里,通过使用敏感且特异的胃泌素放射免疫测定法并结合包括静脉注射促胰液素、钙剂和进食在内的激发试验,在14例疑似患者中确诊了9例新的胃泌素瘤患者。传统的上消化道造影、计算机断层扫描(CAT)、动脉造影和内镜检查除了证实溃疡病的存在外,未提供其他额外信息。9例患者中只有3例基础血浆胃泌素水平超过200 pmol/L(正常空腹血浆胃泌素水平低于25 pmol/L)。3例患者出现急性溃疡穿孔,由于存在多发溃疡和胰腺肿块而怀疑胃泌素瘤。另外3例患者既往十二指肠溃疡手术失败。1例有消化不良、基础血浆胃泌素水平高、促胰液素和钙剂输注试验阴性但进食试验阳性的患者被诊断为G细胞增生;活检和胃窦胃泌素提取证实了这一诊断。单纯胃窦切除术使病情治愈。在所有接受检测的患者中,钙剂输注试验或促胰液素推注试验阳性(较基础值升高超过100%)强烈提示胃泌素瘤诊断,手术证实了这一点。对于急性穿孔患者,最初采用网膜修补术和西咪替丁治疗使2例患者存活,而第3例患者急诊全胃切除术后因食管空肠漏死亡。择期手术患者在全胃切除术前先用西咪替丁治疗至少两周。该组患者无手术死亡,术后发病率极低。本系列病例说明了三个要点:(1)使用胃泌素放射免疫测定法和激发试验对溃疡患者进行仔细筛查能够提高胃泌素瘤的检出率,而传统检查价值不大;(2)在适当病例中保持高度怀疑指数很有必要;(3)在择期情况下进行全胃切除术是安全的,能使患者恢复正常健康生活,而不会出现侵袭性消化性溃疡的后遗症或每日服药。